A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma

Tools

Item Type:	Letter
Title:	A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma
Creators Name:	Krüger, J., Obenaus, M., Blau, I.W., Hoser, D., Vaegler, M., Rauschenbach, H., Anagnostopoulos, I., Jöhrens, K., Scheuplein, V., Kieback, E., Böhme, J., Von Brünneck, A.C., Krönke, J., Busse, A., Willimsky, G., Blankenstein, T., Pezzutto, A., Keller, U. and Nogai, A.
Keywords:	Multiple Myeloma, MAGE-A1, T Cell Receptor (TCR), TCR T Cell Therapy
Source:	Haematologica
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date:	12 September 2024
Official Publication:	https://doi.org/10.3324/haematol.2024.286124
PubMed:	View item in PubMed

Repository Staff Only: item control page